Lonza launches Singapore Media Development Lab to cut biomanufacturing risk
The move comes as drug developers face mounting pressure from faster timelines and increasingly complex manufacturing processes
The move comes as drug developers face mounting pressure from faster timelines and increasingly complex manufacturing processes
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
India’s largest glycolic acid manufacturer will unveil AviGa Bio HP70 on April 14, 2026
Both companies say the collaboration is driven by a shared mission to improve patient outcomes by aligning every step of the diagnostic process
This linear, covalently closed, double-stranded DNA offers a rapid, cell-free alternative to traditional plasmid DNA, addressing a critical bottleneck in nucleic acid therapeutics development
The move aims to accelerate drug discovery with AI-driven designs powered by NVIDIA technology
The newly classified assays join Roche’s Ionify 25-Hydroxy Vitamin D total assay in a growing U.S. portfolio
At the center of the collapse is opposition from the Federal Trade Commission
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
The partnership will focus on advancing fault-tolerant quantum algorithms and developing clinically relevant quantum applications
Subscribe To Our Newsletter & Stay Updated